HEADER TRANSFERASE 07-FEB-17 5N23 TITLE PROTEIN KINASE A MUTANTS AS SURROGATE MODEL FOR AURORA B WITH AT9283 TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: PKI-ALPHA,CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 12 MUSCLE/BRAIN ISOFORM; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR PRAR; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 OTHER_DETAILS: SYNTHESIZED FROM GL BIOCHEM COMPANY, CHINA KEYWDS AT9283, SURROGATE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.A.ALAM,U.ROTHWEILER,R.A.ENGH REVDAT 3 23-OCT-24 5N23 1 REMARK REVDAT 2 17-JAN-24 5N23 1 REMARK REVDAT 1 14-MAR-18 5N23 0 JRNL AUTH K.A.ALAM,R.A.ENGH JRNL TITL INHIBITOR INDUCED STRUCTURAL EFFECTS INVOLVING PHE327 IN AGC JRNL TITL 2 KINASES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 25480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.4727 - 5.0303 0.94 1744 143 0.1806 0.2272 REMARK 3 2 5.0303 - 3.9936 0.97 1702 149 0.1524 0.1662 REMARK 3 3 3.9936 - 3.4890 0.95 1667 146 0.1683 0.2516 REMARK 3 4 3.4890 - 3.1701 0.98 1683 142 0.1878 0.2291 REMARK 3 5 3.1701 - 2.9429 0.98 1710 146 0.1999 0.2453 REMARK 3 6 2.9429 - 2.7695 0.96 1634 136 0.1924 0.2698 REMARK 3 7 2.7695 - 2.6308 0.98 1685 146 0.2052 0.2927 REMARK 3 8 2.6308 - 2.5163 0.99 1679 143 0.2028 0.2412 REMARK 3 9 2.5163 - 2.4194 0.99 1665 140 0.2038 0.2723 REMARK 3 10 2.4194 - 2.3359 0.98 1676 149 0.2161 0.2751 REMARK 3 11 2.3359 - 2.2629 0.96 1632 137 0.2132 0.3106 REMARK 3 12 2.2629 - 2.1982 0.99 1674 140 0.2388 0.3047 REMARK 3 13 2.1982 - 2.1403 0.99 1684 140 0.2478 0.3241 REMARK 3 14 2.1403 - 2.0881 0.96 1642 146 0.2430 0.2739 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3079 REMARK 3 ANGLE : 0.896 4162 REMARK 3 CHIRALITY : 0.053 427 REMARK 3 PLANARITY : 0.005 526 REMARK 3 DIHEDRAL : 14.790 1806 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5N23 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1200003297. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976251 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED CHANNEL REMARK 200 -CUT SILICON MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25483 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.088 REMARK 200 RESOLUTION RANGE LOW (A) : 39.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.06576 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3AMA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12-26 % (V/V) METHANOL, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.97000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.27000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.97000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.27000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 PRO A 195A REMARK 465 LYS A 319 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP A 323 REMARK 465 THR A 324 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 317 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NZ LYS A 8 N THR B 5 4445 1.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 112 -158.96 -134.41 REMARK 500 ASP A 166 43.93 -148.41 REMARK 500 ASP A 184 94.27 72.70 REMARK 500 ASN A 216 -159.08 -143.42 REMARK 500 LEU A 273 44.62 -84.00 REMARK 500 LYS A 317 109.34 -54.77 REMARK 500 ASN A 326 18.09 -145.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 35R A 401 DBREF 5N23 A 0 350 UNP P17612 KAPCA_HUMAN 1 351 DBREF 5N23 B 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQADV 5N23 ARG A 47 UNP P17612 LYS 48 ENGINEERED MUTATION SEQADV 5N23 GLN A 95 UNP P17612 LEU 96 ENGINEERED MUTATION SEQADV 5N23 LEU A 120 UNP P17612 MET 121 ENGINEERED MUTATION SEQADV 5N23 ALA A 123 UNP P17612 VAL 124 ENGINEERED MUTATION SEQADV 5N23 LYS A 181 UNP P17612 GLN 182 ENGINEERED MUTATION SEQADV 5N23 ALA A 183 UNP P17612 THR 184 ENGINEERED MUTATION SEQADV 5N23 PRO A 195A UNP P17612 INSERTION SEQRES 1 A 352 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN SEQRES 2 A 352 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 352 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 A 352 HIS LEU ASP GLN PHE GLU ARG ILE ARG THR LEU GLY THR SEQRES 5 A 352 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 A 352 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 352 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 352 GLU LYS ARG ILE GLN GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 352 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 352 TYR MET VAL LEU GLU TYR ALA PRO GLY GLY GLU MET PHE SEQRES 11 A 352 SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU PRO HIS SEQRES 12 A 352 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 352 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 352 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE LYS SEQRES 15 A 352 VAL ALA ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 352 THR PRO TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA SEQRES 17 A 352 PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL SEQRES 18 A 352 ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA SEQRES 19 A 352 ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN SEQRES 20 A 352 ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SEQRES 21 A 352 SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN SEQRES 22 A 352 LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU SEQRES 23 A 352 LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE SEQRES 24 A 352 ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL SEQRES 25 A 352 GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP SEQRES 26 A 352 THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG SEQRES 27 A 352 VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU SEQRES 28 A 352 PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 5N23 SEP A 10 SER MODIFIED RESIDUE MODRES 5N23 SEP A 139 SER MODIFIED RESIDUE MODRES 5N23 TPO A 197 THR MODIFIED RESIDUE MODRES 5N23 SEP A 338 SER MODIFIED RESIDUE HET SEP A 10 10 HET SEP A 139 10 HET TPO A 197 11 HET SEP A 338 10 HET 35R A 401 56 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM 35R 1-CYCLOPROPYL-3-{3-[5-(MORPHOLIN-4-YLMETHYL)-1H- HETNAM 2 35R BENZIMIDAZOL-2-YL]-1H-PYRAZOL-4-YL}UREA HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 35R C19 H23 N7 O2 FORMUL 4 HOH *133(H2 O) HELIX 1 AA1 GLY A 9 SER A 32 1 24 HELIX 2 AA2 HIS A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 GLN A 96 1 13 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SEP A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 SER A 252 1 11 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 ASP A 276 ARG A 280 5 5 HELIX 14 AB5 VAL A 288 ASN A 293 1 6 HELIX 15 AB6 HIS A 294 ALA A 298 5 5 HELIX 16 AB7 ASP A 301 GLN A 307 1 7 HELIX 17 AB8 THR B 6 ALA B 12 1 7 SHEET 1 AA1 5 PHE A 43 GLY A 52 0 SHEET 2 AA1 5 GLY A 55 HIS A 62 -1 O LEU A 59 N ARG A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O LEU A 120 N ALA A 70 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N PHE A 108 O VAL A 119 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O LYS A 181 N LEU A 173 LINK C GLY A 9 N SEP A 10 1555 1555 1.33 LINK C SEP A 10 N GLU A 11 1555 1555 1.33 LINK C PHE A 138 N SEP A 139 1555 1555 1.33 LINK C SEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 CISPEP 1 LYS A 8 GLY A 9 0 15.39 SITE 1 AC1 14 LEU A 49 GLY A 50 ALA A 70 LEU A 120 SITE 2 AC1 14 GLU A 121 TYR A 122 ALA A 123 PRO A 124 SITE 3 AC1 14 GLY A 126 SER A 130 LEU A 173 ASP A 184 SITE 4 AC1 14 PHE A 327 ASP A 328 CRYST1 72.000 74.540 79.940 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013889 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013416 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012509 0.00000